| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $85.1M | — | +3.4% |
| Cost of Revenue | $47.2M | — | +2.9% |
| Gross Profit | $37.9M | — | +4.1% |
| R&D Expense | $5.1M | — | +26.4% |
| SG&A Expense | $17.5M | — | +7.8% |
| Operating Income | -$9.3M | — | -21.9% |
| Pre-tax Income | -$8.5M | — | -35.5% |
| Income Tax | -$174K | — | -79.4% |
| Net Income | -$8.3M | — | -34.8% |
| EPS (Basic) | -$0.30 | — | -20.0% |
| EPS (Diluted) | -$0.30 | — | -20.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $93.1M | -10.2% | -21.7% |
| Accounts Receivable | $41.9M | +7.7% | +14.3% |
| Inventory | $25.0M | -3.8% | -4.9% |
| Current Assets | $190.7M | -3.8% | -5.0% |
| Total Assets | $285.9M | -4.3% | -7.3% |
| Current Liabilities | $61.4M | -3.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.7M | — | +60.2% |
| Capital Expenditures | $210K | — | -28.1% |
| Investing Cash Flow | -$2.0M | — | +3.1% |
| Financing Cash Flow | -$2.1M | — | -108.9% |
| Free Cash Flow | -$6.9M | — | +59.6% |
| -6.1% |
| Total Liabilities | $103.0M | -3.2% | -6.7% |
| Stockholders' Equity | $182.9M | -4.9% | -7.6% |